HealthWarehouse.com Reports 194% Increase in Q1 Sales with Net Income of $178,000 and Adjusted EBITDA of $521,000

Reuters
13 May
HealthWarehouse.com Reports 194% Increase in Q1 Sales with Net Income of $178,000 and Adjusted EBITDA of $521,000

HealthWarehouse.com Inc. reported strong financial results for the first quarter of 2025, with net sales reaching $15.0 million, marking a 194% increase compared to the same period in 2024. This significant growth was driven by a 616% increase in partner services revenues. The company also reported a net income of $178,000 for the quarter, a notable improvement from the net loss of $252,000 reported in the first quarter of 2024. Additionally, HealthWarehouse.com recorded an Adjusted EBITDA of $521,000, up from $90,000 in the previous year's quarter. HealthWarehouse.com continues to focus on its healthcare e-commerce platform, which aims to enhance access to and reduce the cost of healthcare products for consumers and business partners across all 50 states.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthWarehouse.com Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250512755871) on May 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10